Morphologic effects of neoadjuvant chemotherapy in locally advanced breast cancer (Q73447206)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9198104%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

title

Morphologic effects of neoadjuvant chemotherapy in locally advanced breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9198104%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

neoadjuvant chemotherapy

1 reference

1 reference

Moll UM

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9198104%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Chumas J

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9198104%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

publication date

1 January 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9198104%20AND%20SRC:MED&resulttype=core&format=json

Pathology, Research and Practice

4 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9198104%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

193

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9198104%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9198104%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

187-196

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9198104%20AND%20SRC:MED&resulttype=core&format=json

Primary systemic therapy for operable breast cancer

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2897%2980076-3

7 January 2021

Immunohistochemical detection of p53 protein in mammary carcinoma: an important new independent indicator of prognosis?

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2897%2980076-3

7 January 2021

Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2897%2980076-3

7 January 2021

Sequential cytopunctures during preoperative chemotherapy for primary breast carcinoma. Cytomorphologic changes, initial tumor ploidy, and tumor regression

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2897%2980076-3

7 January 2021

Combined chemotherapy-radiotherapy approach in locally advanced (T3b-T4) breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2897%2980076-3

7 January 2021

Histologic grade of locally advanced infiltrating ductal carcinoma after treatment with induction chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2897%2980076-3

7 January 2021

Effects of chemotherapy on pathologic and biologic characteristics of locally advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2897%2980076-3

7 January 2021

Treatment of locoregionally advanced breast cancer with surgery, radiotherapy, and combination chemoimmunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2897%2980076-3

7 January 2021

Primary chemotherapy for early and advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2897%2980076-3

7 January 2021

Two years of high-dose cyclophosphamide and 5-fluorouracil followed by surgery after 3 months for acute inflammatory breast carcinomas. A phase II study of 25 cases with a median follow-up of 35 months

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2897%2980076-3

7 January 2021

Results of a conservative treatment combining induction (neoadjuvant) and consolidation chemotherapy, hormonotherapy, and external and interstitial irradiation in 98 patients with locally advanced breast cancer (IIIA-IIIB)

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2897%2980076-3

7 January 2021

The effects of hormonal and chemotherapy on tumoral and nonneoplastic breast tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2897%2980076-3

7 January 2021

Effects of primary chemotherapy in conservative treatment of breast cancer patients with operable tumors larger than 3 cm. Results of a randomized trial in a single centre

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2897%2980076-3

7 January 2021

p53-dependent and p53-independent activation of apoptosis in mammary epithelial cells reveals a survival function of EGF and insulin.

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2897%2980076-3

7 January 2021

p53 mediated tumor cell response to chemotherapeutic DNA damage: a preliminary study in matched pairs of breast cancer biopsies

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2897%2980076-3

7 January 2021

Multimodal therapy for locally advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2897%2980076-3

7 January 2021

Combination chemotherapy with mastectomy or radiotherapy for stage III breast carcinoma: a Cancer and Leukemia Group B study

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2897%2980076-3

7 January 2021

Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2897%2980076-3

7 January 2021

The effects of chemotherapy on morphology, cellular proliferation, apoptosis and oncoprotein expression in primary breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2897%2980076-3

7 January 2021

Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: preliminary results of a randomised trial: S6

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2897%2980076-3

7 January 2021

10.1016/S0344-0338(97)80076-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9198104%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference